Sonya Prasad

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

15

H-Index

1

About

Dr. Sonya Prasad is a distinguished researcher in urologic oncology, with a primary focus on improving the diagnostic accuracy and clinical management of prostate cancer. Her most impactful work centers on the comparative efficacy of multiparametric magnetic resonance imaging (mpMRI) guided fusion biopsy versus the traditional 12-core systematic biopsy. In her highly cited 2019 study, Dr. Prasad demonstrated that fusion biopsy significantly reduces the risk of downgrading the Grade Group after radical prostatectomy, a critical finding that enhances risk stratification and treatment planning. This work, garnering 15 citations, has helped refine biopsy protocols, minimizing both overdiagnosis and underdetection of clinically significant disease. Dr. Prasad’s contributions are pivotal in advancing precision medicine for prostate cancer, directly influencing how clinicians integrate advanced imaging into routine practice. Her research underscores a commitment to evidence-based improvements in patient outcomes, making her a notable voice in the ongoing evolution of urologic diagnostics.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Resonance Imaging Guided Fusion Biopsy and Standard 12-Core Biopsy
15 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago